Topic · Oncology · Medicine
Cancer-related Molecular Pathways
OpenAlex topic; a paper is listed when OpenAlex scores it at least 0.5 for this topic.
138 papers
The research progress of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer
Jie Xian, Yu Cheng, Xue Ying Qin, Yequn Luo, Yijia Cao, Youde Cao
This study investigates Numb's role in regulating p53 activity in triple-negative breast cancer, showing Numb promotes p53 stability and is associated with lower Ki67 levels.
Journal of Cellular and Molecular Medicine · Jun 5, 2020Peer-reviewedMolecular Biology
Frequency switching between oscillatory homeostats and the regulation of p53
Peter Ruoff, Nobuaki Nishiyama
The paper examines how p53 regulation shifts between oscillatory and non-oscillatory states in response to DNA damage, highlighting the roles of Per2, ATM, and Mdm2 in maintaining homeostasis.
PLoS ONE · May 20, 2020Peer-reviewedSystems Biology
The TRF2 General Transcription Factor Is a Key Regulator of Cell Cycle Progression
Adi Kedmi, Anna Sloutskin, Natalie Epstein, Lital Gasri-Plotnitsky, Debby Ickowicz, Irit Shoval, Tirza Doniger, Eliezer Darmon, Diana Ideses, Ziv Porat, Orly Yaron, Tamar Juven‐Gershon
This study identifies TRF2 as a key regulator of cell cycle progression in Drosophila cells, showing its role in controlling cyclin expression and interacting with co-factors GFZF and M1BP.
bioRxiv · Mar 27, 2020 · PreprintMolecular Biology
p53-induced apoptosis is specified by a translation program regulated by PCBP2 and DHX30.
Dario Rizzotto, Sara Zaccara, Annalisa Rossi, Matthew D. Galbraith, Zdeněk Andrysík, Ahwan Pandey, Kelly D. Sullivan, Alessandro Quattrone, Joaquin Maximiliano Espinosa, Erik Dassi, Alberto Inga
This study identifies a translational control mechanism regulated by PCBP2 and DHX30 that determines the outcome of p53 activation by Nutlin, shifting the response from cell cycle arrest to apoptosis.
Cell Reports · Mar 1, 2020Peer-reviewedMolecular Biology
Locally acting transcription factors are required for p53-dependent cis-regulatory element activity
Allison N. Catizone, Gizem Karsli Uzunbas, Petra Celadova, Sylvia Kuang, Daniel A. Bose, Morgan A. Sammons
The paper investigates how local transcription factors influence p53-bound cis-regulatory elements, showing that co-regulatory factors and sequence context affect CRE activity and gene expression.
Nucleic Acids Research · Feb 26, 2020Peer-reviewedMolecular Biology
Identification of universal and cell type specific p53 DNA binding
Antonina Hafner, Lyubov Kublo, Michael Tsabar, Galit Lahav, Jacob Stewart-Ornstein
The paper identifies universal and cell type specific p53 DNA binding sites by analyzing 12 epithelial cell lines after ionizing radiation.
BMC Molecular and Cell Biology · Feb 18, 2020Peer-reviewedGenomics
MXD/MIZ1 complexes activate transcription of MYC-repressed genes
Anton Shostak, Géza Schermann, Axel C. R. Diernfellner, Michael Brunner
The paper shows that MXD proteins can activate transcription of MYC-repressed genes through interaction with MIZ1 and a functional DNA binding domain, revealing reciprocal antagonism between MXD and MYC in gene regulation.
bioRxiv · Nov 15, 2019 · PreprintMolecular Biology
Diversification of retinoblastoma protein function associated with cis and trans adaptations
Rima Mouawad, Jaideep Prasad, Dominic Thorley, Pamela Himadewi, Dhruva Kadiyala, Nathan J. Wilson, Philipp Kapranov, David N. Arnosti
This study investigates the functional diversification of retinoblastoma proteins in Drosophila, showing that Rbf2 regulates distinct gene sets and has specialized roles in reproductive development.
Molecular Biology and Evolution · Aug 12, 2019Peer-reviewedDevelopmental Biology
Cell type-dependent control of p53 transcription and enhancer activity by p63
Gizem Karsli Uzunbas, Faraz Ahmed, Morgan A. Sammons
The paper shows that p53's transcriptional activity varies by cell type and is influenced by p63's role in enhancer binding and maintenance in epithelial cells.
Journal of Biological Chemistry · May 21, 2019Peer-reviewedGenomics
Comparison of genotoxic vs. non-genotoxic stabilization of p53 provides insight into parallel stress-responsive transcriptional networks
Allison N. Catizone, Charly Ryan Good, Katherine A. Alexander, Shelley L. Berger, Morgan A. Sammons
The paper compares genotoxic and non-genotoxic p53 activation in human fibroblasts, showing similar genome-wide binding and chromatin changes but distinct inflammatory gene expression patterns.
Cell Cycle · Apr 9, 2019Peer-reviewedGenomics
Cyclin A2/Cdk1 is Essential for the in vivo S Phase Entry by Phosphorylating Top2a.
Miaomiao Jin, Ruikun Hu, Baijie Xu, Weilai Huang, Hong Wang, Bo Chen, Jie He, Ying Cao
This study shows that Cdk1 interacts with Cyclin A2 to phosphorylate Top2a, enabling S phase entry, and with Cyclin B1 to regulate M phase progression in zebrafish embryos.
bioRxiv · Jan 7, 2019 · PreprintDevelopmental Biology
Variable sensitivity to DNA damaging chemotherapeutic modulated by cell type-dependent bimodal p53 dynamics
Ruizhen Yang, Bo Yuan Huang, Yanting Zhu, Yang Li, Feng Liu, Jue Shi
This study identifies bimodal p53 dynamics as a mechanism modulating resistance to DNA damaging chemotherapy, showing that ATM expression determines sensitivity and that inhibiting Mdm2 and Wip1 can sensitize resistant cells.
Science Advances · Dec 7, 2018Peer-reviewedSystems Biology
Transcriptome Profiling Reveals Inhibitory Effect of Down-regulated ZBTB38 gene on the Transcriptional Regulation of Tumor Cells Proliferation
Jie Chen, Chaofeng Xing, Haosen Wang, Zongmeng Zhang, Daolun Yu, Jie Li, Honglin Li, Jun Li, Yafei Cai
The paper identifies 2,438 differentially expressed genes in ZBTB38-knockout SH-SY5Y cells, showing ZBTB38 inhibits tumor cell proliferation by regulating cell cycle arrest and autophagy suppression.
bioRxiv · Jun 19, 2018 · PreprintGenomics
The RASSF6 tumor suppressor protein regulates apoptosis and cell cycle progression via Retinoblastoma protein.
Shakhawoat Hossain, Hiroaki Iwasa, Aradhan Sarkar, Junichi Maruyama, Kyoko Arimoto‐Matsuzaki, Yutaka Hata
This study identifies RASSF6 as a tumor suppressor that regulates apoptosis and cell cycle progression through pRb, independent of p53.
Molecular and Cellular Biology · Jun 12, 2018Peer-reviewedMolecular Biology
The Wild-type and Gain-of-function Mutant p53 Enhance p300 Autoacetylation through Conformational Switching
Stephanie Kaypee, Raka Ghosh, Smitha Asoka Sahadevan, Shilpa Patil, Manidip Shasmal, Piya Ghosh, Neeladri Sekhar Roy, Jayati Sengupta, Siddhartha Roy, Tapas Kumar Kundu
This study shows that p53 enhances p300 autoacetylation through structural changes, which is critical for gene regulation and may be targeted to treat tumors.
bioRxiv · May 4, 2018 · PreprintMolecular Biology
TP53 Intron Derived Concentrations Implicate p53
Kevin Bermeister, Jonathan Dyne, Xinghao Yu, Liran Carmel, Khens Kermesh, Adam Bermeister, Mark Kon, Daniel Shnier
The paper investigates TP53 intronic half-sites and their potential role in p53 regulation across multiple genes.
bioRxiv · Apr 25, 2018 · PreprintBioinformatics
HMGA1 zebrafish co-orthologue hmga1b can modulate p53-dependent cellular responses but is unable to control the alternative splicing of psen1
Seyyed Hani Moussavi Nik, Morgan Newman, Amanda L. Lumsden, Tanya Jayne, Michael T. Lardelli
The paper shows that hmga1b in zebrafish can modulate p53-dependent cellular responses but not alternative splicing of psen1, similar to hmga1a.
bioRxiv · Jan 2, 2018 · PreprintDevelopmental Biology